Brief: Neovacs H1 Operating Loss Narrows To 4.6 Million Euros
03/10/2019 06:35
Oct 3 (Reuters) - NEOVACS SA ALNEV.PA :
* ANNOUNCED ON WEDNESDAY H1 NET LOSS EUR 3.8 MLN VS LOSS EUR
6.1
MLN YEAR AGO
* H1 OPERATING LOSS EUR 4.6 MLN VS LOSS EUR 6.6 MLN YEAR AGO
* H1 OPERATING INCOME EUR 264,000 VS EUR 19,000 YEAR AGO
* CASH BALANCE AS AT 30 JUNE 2019 IMPROVED: EUR 3.5 MLN VS.
EUR
1.4 MLN ON 31 DECEMBER 2018
Source text for Eikon: urn:newsml:reuters.com:*:nGNE67p8VD
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants